Actively Recruiting
Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer
Led by Ohio State University Comprehensive Cancer Center · Updated on 2025-05-31
157
Participants Needed
1
Research Sites
107 weeks
Total Duration
On this page
Sponsors
O
Ohio State University Comprehensive Cancer Center
Lead Sponsor
N
National Comprehensive Cancer Network
Collaborating Sponsor
AI-Summary
What this Trial Is About
This clinical trial evaluates earlier symptom management through remote electronic symptom monitoring (such as through an app on patient's phone), and accessibility of palliative care self-referral by patients with thoracic cancer and caregivers by proxy (legal representative). Thoracic cancer occurs in the chest and often causes symptoms for patients. Patients and/or their caregivers are often unable to attend in-person clinic visits for various reasons. The most frequently reported symptom by patients at initial palliative care consultations is pain, and caregivers' most common concerns are pain management for the patient, stress reduction, and fears about patient decline. Earlier palliative care referral can help control these symptoms before they worsen, providing a better quality of life for patients and caregivers. improve physical and emotional functioning for patients and caregivers in cancer care. This study may help researchers learn how an electronic symptom monitoring program may provide an earlier and more accessible way for patients with thoracic cancer to receive palliative care.
CONDITIONS
Official Title
Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older
- Diagnosed with any stage (1-4) or type of thoracic malignancy including non-small cell lung cancer, small cell lung cancer, mesothelioma, or thymic carcinoma
- At least 2 visits at the Ohio State University Comprehensive Cancer Center Thoracic Oncology Clinic
- Enrollment within 12 weeks of the initial Thoracic Medical Oncology appointment
- Ability to understand and willingness to sign informed consent
- Ability to read and understand English
- Access to a device with email or text messaging capability
- Caregivers aged 18 years or older
- Identified by the patient as primary caregiver
- Corresponding patient has consented to participate
- Caregivers able to understand and willing to sign informed consent
- Caregivers able to read and understand English
- Caregivers have access to a device with email or text messaging capability
You will not qualify if you...
- Patients who have been previously referred to ambulatory palliative care
- Prisoners
- Pregnant patients
- Patients who lack capacity for medical decision-making as determined by their primary oncologist
- No exclusions based on ECOG performance status, lab values, prior cancer diagnoses, comorbidities, or brain metastases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210
Actively Recruiting
Research Team
T
The Ohio State Comprehensive Cancer Center
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here